熟悉更多不同的資助計劃助你成就科研發展。

理大與業界夥伴的合作研究

政府資助

• 創新及科技基金
• + 創新及科技支援計劃
  創新及科技支援計劃支援由指定本地公營科研機構及研發中心所進行的研發項目。創新及科技支援計劃每年接受一次申請。計劃資助平台項目(以產業為本，並具商品化潛力的應用研發項目)及種子項目（具探索性和前瞻性的項目）。
• + 夥伴研究計劃
  夥伴研究計劃旨在支持私營公司與本地大學／科研機構合作開展的研發項目。為產生協同效應和增加靈活性，夥伴研究計劃把大學與產業合作計劃和創新及科技支援計劃下的合作項目類別整合為一項計劃。夥伴研究計劃向獲批項目提供等額資助，項目期最長為三年，全年均接受申請。（計劃詳情請按此）
• + 院校中游研發計劃
  為大學教育資助委員會資助大學提供資助，藉此鼓勵大學在技術領域進行更多中游應用研究項目。（計劃詳情請按此）
• + 協作研究金2021/22
  協作研究金旨在資助由多名學者合作的跨學科研究項目，希望鼓勵研究單位進行更多具創意及高質素的跨學科研究項目。 (詳情請按此）
• + 創科生活基金
  創科生活基金目的是資助令市民生活更方便、舒適及安全，或照顧特殊社群需要的創新及科技（「創科」）項目。（計劃詳情請按此）
• + 內地與香港聯合資助計劃(MHKJFS)2021
  香港特區政府與國家科學技術部簽署創科合作安排及研發資助協議，共同推動各項創新科技合作。2021年具體詳情如下:

  • 國家科技部通知2021 (按此)
  • 創新科技署MHKJFS連結 (按此)
  • 理大研究事務處MHKJFS連結 (按此)

  
  若有任何查詢, 請與ITDO楊曉鋒先生聯絡(電話: 3400 2815/ 電郵: hfyeung@polyu.edu.hk)。
• + 理工-江蘇科研合作平台
  江蘇企業技術需求統計 2021
  江蘇重點産業合作需求清單2021
  若對江蘇的項目感興趣，請與楊曉鋒先生聯絡 (電話: 3400-2815 /電郵: hfyeung@polyu.edu.hk)
• + 江蘇省產業技術研究院合作研究項目-初步建議書
  江蘇省產業技術研究院 (JITRI) 為理大PI設立每年2000萬元人民幣的資金經費，為JITRI專門機構/ JITRI研究所衍生公司合作研究項目提供研究經費。 資金金額取決於研究所與PI之間的共同協議。重點領域包括材料與能源環保、信息技術、生物醫藥和高端裝備製造。JIRTI已經與理大 PI展開了成功的項目。
  請與ITDO楊曉鋒先生聯絡(電話: 3400 2815/ 電郵: hfyeung@polyu.edu.hk)，與JITRI進行技術配對。
• + 粵港科技創新聯合資助項目 (TCFS-C1)
  為促進粵港創新資源共享，提升兩地自主創新能力，積極推動粵港澳大灣區國際科技創新中心建設，圍繞粵港兩地科技創新合作需求，推動項目合作研發與產業化落地。重點領域包括新一代資訊技術、半導體與積體電路、人工智能、金融科技、生物醫藥、食品安全、新材料、新能源、節能環保（大氣及水污染治理）、先進製造、海洋科學等，優先支持與新冠病毒疫情防控有關的研發專案。具體內容請 按此 及參閱以下資訊：

  • Appendix 1: 粵港科技合作政策(2020)
  • Appendix 2: 2020/2021年度申報指南

  
  如有任何查詢，請與ITDO楊曉鋒先生聯絡。(電話:3400 2815 / 電郵: hfyeung@polyu.edu.hk)
• + Green Tech Fund
  The Government announced in the 2020-21 Budget that HK$200 million would be allocated for setting up the new GTF to provide better and more focused funding support for the R&D and application of decarbonisation and green technologies, so as to expedite low-carbon transformation and enhance environmental protection in Hong Kong.(Click here for more details)
• + Smart Traffic Fund
  In the 2019 Policy Address Supplement, the Chief Executive announced the setup of the Smart Traffic Fund (“Fund”) to provide funding support to local organisations or enterprises for conducting research and application of innovation and technology with the objectives of enhancing commuting convenience, enhancing efficiency of the road network or road space, and improving driving safety. $1 billion have been earmarked for the Fund, which commences operation in 2020-21.
  The Transport Department has engaged the Hong Kong Productivity Council as the Implementation Partner to serve as the Secretariat for the Fund. The Fund aims to provide support for enterprises or organizations to conduct research and application on vehicle-related I&T with at least one of the following objectives:

  
  
  • Enhancing convenience of motorists;
  • Enhancing efficiency of the road network or road space; and
  • Improving driving safety.

  
  For enquiry, please visit HKPC website

企業資助計劃

• + 阿里巴巴集團計劃（計劃詳情，請與ITDO聯絡）
  • 阿里巴巴訪問學者
  • 阿里巴巴創新研究項目
  • 阿里巴巴技術研討會／論壇
• + 華為技術有限公司計劃（計劃詳情，請與ITDO聯絡）
  • 理大 - 華為光學網絡與先進計算系統聯合實驗室
  • 華為合作研究項目
  • 華為創新研究項目
  • 華為技術論壇
• + CIC Research and Technology Development Fund
  The CIC Research and Technology Development Fund (R&D Fund) is set up to provide financial support for research projects which can benefit the Hong Kong construction industry through practical application of the research outcomes, covering the areas of (i) Building Information Modelling (BIM); (ii) Construction Procurement and Project Management; (iii) Construction Productivity; (iv) Construction Safety; and (v) Green Construction.
  For enquiry, please visit CIC website
• + Pfizer’s Centers for Therapeutic Innovation (CTI) Call for Proposals (CFP)
  Pfizer’s Centers for Therapeutic Innovation (CTI) Call for Proposals (CFP) - areas of interest and the timeline for submission of non-confidential pre-proposals for 2021 is now available. CTI focuses on accessing cutting-edge science and innovative discoveries aligned with Pfizer’s current core research areas of Oncology, Inflammation & Immunology, Rare Diseases, and Internal Medicine. The specific interests for the 2021 CFP can be found here, or online at pfizercti.com. Deadline to submit pre-proposals to Pfizer for consideration: June 28, 2021.
  If you are interested in submitting a pre-proposal, please contact Ms Nelly Lam of ITDO, Email: nelly.lam@polyu.edu.hk; Tel: 3400 2819.
• + Zoetis 2021 Research Alliance Interests
  Zoetis is a global animal health company dedicated to supporting customers and their businesses in ever better ways. Building on more than 65 years of experience, it delivers quality medicines, vaccines and diagnostic products, complemented by biodevices, genetic tests and precision livestock farming. Areas of emphasis: digital healthcare, machine learning and diagnostic techniques applied to pharmaceutical R&D, genomics, transcriptomics or proteomics enabling rational drug and vaccine design. Click here for details.
  If you are interested in partnership opportunity with Zoetis, please contact Ms Nelly Lam, Email: nelly.lam@polyu.edu.hk; Tel: 3400 2819.

為理大成員而設的其他合作計劃

理大的科研專才可透過ITDO的全球網絡與不同的機構拓展合作機會

更多資助計劃，請瀏覽研究事務處網頁